Bristol-Myers Squibb Company
Utility Patent Applications
Last updated:
List of all Bristol-Myers Squibb Company patents 438 in total
| Status | Patent |
|---|---|
Application | Utility: ANTI-ICOS AGONIST ANTIBODIES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 3 Oct 2019 |
Application | Utility: HETEROCYCLIC SULFONES AS ROR GAMMA MODULATORS Filling date: 6 Sep 2025 Issue date: 3 Oct 2019 |
Application | Utility: BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS Filling date: 6 Sep 2025 Issue date: 3 Oct 2019 |
Application | Utility: SPIRO-FUSED CYCLIC UREAS AS INHIBITORS OF ROCK Filling date: 6 Sep 2025 Issue date: 3 Oct 2019 |
Application | Utility: LACTAM, CYCLIC UREA AND CARBAMATE, AND TRIAZOLONE DERIVATIVES AS POTENT AND SELECTIVE ROCK INHIBITORS Filling date: 6 Sep 2025 Issue date: 3 Oct 2019 |
Application | Utility: TGF Beta RECEPTOR ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: ANTI-PD-1 ANTIBODY FOR USE IN A METHOD OF TREATMENT OF RECURRENT SMALL CELL LUNG CANCER Filling date: 6 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: TREATMENT OF HODGKIN LYMPHOMA USING AN ANTI-PD-1 ANTIBODY Filling date: 6 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: HETEROARYL SUBSTITUTED AMINOPYRIDINE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: RADIOLIGANDS FOR IMAGING THE IDO1 ENZYME Filling date: 6 Sep 2025 Issue date: 19 Sep 2019 |
Application | Utility: COMBINATION THERAPY WITH ANTI-CD73 ANTIBODIES Filling date: 6 Sep 2025 Issue date: 19 Sep 2019 |
Application | Utility: CAMK2D ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: TRICYCLIC RHO KINASE INHIBITORS Filling date: 6 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: GSK-3 INHIBITORS Filling date: 6 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: PHENYLPYRROLIDINONE FORMYL PEPTIDE 2 RECEPTOR AGONISTS Filling date: 6 Sep 2025 Issue date: 5 Sep 2019 |
Application | Utility: CYCLOBUTANE- AND AZETIDINE-CONTAINING MONO AND SPIROCYCLIC COMPOUNDS AS ALPHA V INTEGRIN INHIBITORS Filling date: 6 Sep 2025 Issue date: 5 Sep 2019 |
Application | Utility: 4-HYDROXY-3-(HETEROARYL)PYRIDINE-2-ONE APJ AGONISTS Filling date: 6 Sep 2025 Issue date: 29 Aug 2019 |
Application | Utility: TETRAZOLONE-SUBSTITUTED DIHYDROPYRIDINONE MGAT2 INHIBITORS Filling date: 6 Sep 2025 Issue date: 29 Aug 2019 |
Application | Utility: TREATMENT OF RENAL CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANOTHER ANTI-CANCER AGENT Filling date: 6 Sep 2025 Issue date: 29 Aug 2019 |
Application | Utility: FIBRONECTIN BASED SCAFFOLD PROTEINS HAVING IMPROVED STABILITY Filling date: 6 Sep 2025 Issue date: 29 Aug 2019 |
Application | Utility: 3-SUBSTITUTED PROPIONIC ACIDS AS ALPHA V INTEGRIN INHIBITORS Filling date: 6 Sep 2025 Issue date: 29 Aug 2019 |
Application | Utility: PYRIDYL SUBSTITUTED INDOLE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 29 Aug 2019 |
Application | Utility: OPTIMIZATION OF ANTIBODIES THAT BIND LYMPHOCYTE ACTIVATION GENE-3 (LAG-3), AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 22 Aug 2019 |
Application | Utility: MODIFIED RELAXIN POLYPEPTIDES COMPRISING A PHARMACOKINETIC ENHANCER AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 22 Aug 2019 |
Application | Utility: AZOLE AMIDES AND AMINES AS ALPHA V INTEGRIN INHIBITORS Filling date: 6 Sep 2025 Issue date: 22 Aug 2019 |
Application | Utility: PYRROLE AMIDES AS ALPHA V INTEGRIN INHIBITORS Filling date: 6 Sep 2025 Issue date: 22 Aug 2019 |
Application | Utility: INDAZOLE DERIVATIVES AS ALPHA V INTEGRIN ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 22 Aug 2019 |
Application | Utility: ANTIBODIES TO CD40 Filling date: 6 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: INDOLE CARBOXAMIDE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: BSL2v2c2-Ig POLYPEPTIDES Filling date: 6 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS Filling date: 6 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: Fc FUSION PROTEINS COMPRISING NOVEL LINKERS OR ARRANGEMENTS Filling date: 6 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: SUBSTITUTED BICYCLE HETEROCYCLIC DERIVATIVES USEFUL AS ROMK CHANNEL INHIBITORS Filling date: 6 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: ANTIBODIES AGAINST TIM3 AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: MONOCYCLIC HETEROARYL SUBSTITUTED COMPOUNDS Filling date: 6 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: TRICYCLIC SULFONES AS ROR GAMMA MODULATORS Filling date: 6 Sep 2025 Issue date: 8 Aug 2019 |
Application | Utility: TRICYCLIC SULFONES AS ROR GAMMA MODULATORS Filling date: 6 Sep 2025 Issue date: 1 Aug 2019 |
Application | Utility: GLUCOKINASE ACTIVATORS AND METHODS OF USING SAME Filling date: 6 Sep 2025 Issue date: 1 Aug 2019 |
Showing 400 to 438 of 438 patents.